XEIA Venture Partners

Venture capital investments are made in health and technology sectors.

About XEIA Venture Partners

XEIA Venture Partners is a Financial Services company. Venture capital investments are made in health and technology sectors. It operates on a Commission-Based model in Financial Services and Technology sectors. XEIA Venture Partners offers products and services including Venture Capital Investment. Its focus areas include Financials, Venture Capital, Health Tech Investments and Deep Tech.

Company details

Investments are focused on life sciences, AI, hardware, software, deep tech, and health tech by XEIA Venture Partners. Sectors targeted include brain-computer interfaces, concierge medicine, neurotech for depression, and precision psychedelic therapies. The mission is to advance Human 3, described as a new epoch of health, wellbeing, and performance. Portfolio companies such as NeuroBionics, Superpower, Motif, and Mindstate Design Labs are supported to drive innovation in these areas.

Products & Services of XEIA Venture Partners

XEIA Venture Partners offers a comprehensive portfolio of products and services, including Venture Capital Investment.

Venture Capital Investment
Financial Services

Investments are made in health and tech innovations.

Apps and channels of XEIA Venture Partners

its YouTube channel Human 3 with Brom and Sam has 1.64K subscribers and 30 videos.

Human 3 with Brom and Sam
YouTube 1.64K subscribers 30 videos Science & Technology
Open channel

Videos from XEIA Venture Partners

The most watched videos on XEIA Venture Partners's YouTube channel, Human 3 with Brom and Sam (1.64K subscribers). Click a video to play it here.

Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?!
1.3K views
Compass and ATAI latest news + are Psychedelics BACK in 2025?!
534 views
Analyzing the Compass Pathways Phase 3 Psilocybin trial ($CMPS)
406 views
Investing in Psychedelic BioTech (August 2025 webinar replay)
390 views

More on Human 3 with Brom and Sam.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about XEIA Venture Partners

Investments are focused on life sciences, AI, hardware, software, deep tech, and health tech by XEIA Venture Partners. Sectors targeted include brain-computer interfaces, concierge medicine, neurotech for depression, and precision psychedelic therapies. The mission is to advance Human 3, described as a new epoch of health, wellbeing, and performance. Portfolio companies such as NeuroBionics, Superpower, Motif, and Mindstate Design Labs are supported to drive innovation in these areas.

XEIA Venture Partners offers Venture Capital Investment.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available